Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)

Shanghai Jiao Tong University

Status: Enrolling

Conditions: Marginal Zone Lymphoma

Treatments: Other: All treatment regimen selections and usage will be determined by the physician based on clinical practice and/or the respective drug labels in China.

Study type: Observational

Funder types: Other

Identifiers

NCT06534463

MOTIVE

Details and patient eligibility

About

This study aims to evaluate real-world treatment modalities and their corresponding effectiveness and safety in Chinese patients with marginal zone lymphoma, while also exploratively analyzing patient characteristics and health-related quality of life.

Enrollment: 500 estimated patients

Sex: All

Ages: 14+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Be diagnosed as MZL
• Meet the treatment indications for MZL

Exclusion criteria

• Any reason that, in the investigator's opinion, makes the participant unsuitable to participate in this study.

Trial design

500 participants in 1 patient group

Observational Cohort

Description:

Including newly diagnosed marginal zone lymphoma (MZL) and relapse/refractory MZL participants who meet the treatment indications for MZL and are about to undergo MZL treatment.

Treatment:

Other: All treatment regimen selections and usage will be determined by the physician based on clinical practice and/or the respective drug labels in China.